Dallas 10/29/2010 11:31:04 PM
News / Business

Double-Digit Losers on Friday (NR, PIP, EXAS, AMAG)

Double-Digit Losers on Friday

Newpark Resources, Inc. (NYSE:NR) plunged 30.18% to $5.76 on unusual volumes. For the third-quarter, earnings of the company were $0.09 per share, compared with break-even per share in the same quarter last year.

On average, seven analysts polled by Thomson Reuters expected the company to report earnings of $0.11 per share for the period. Analysts' estimate typically excludes special items.

Total revenues for the quarter were $179.27 million, up from $118.2 million in the prior year quarter. Four Wall Street analysts expected revenues of $187.51 million for the quarter.

PharmAthene, Inc. (AMEX:PIP) slumped 11.76% to $3.60 with over 3.80 million shares. The company announced that it has priced a registered public offering of 4,300,000 shares of its common stock at a price to the public of $3.50 per share. The offering is expected to close on or about November 3, 2010.

The company has Price/Sales ratio of 6.12. The stock has the 50- Day Moving Average and 200-Day Moving Average prices of $2.18 and $1.68 respectively. At current market price, the market capitalization of the company stands at $117.97 million.

EXACT Sciences Corporation (NASDAQ:EXAS) went down 15.64% to $7.23. This week, the company announced its financial results for the third quarter ended September 30, 2010.

The company reported a net loss of ($3.4) million, or ($0.08) a share, for the third quarter of 2010. The company had a net loss of ($1.0) million, or ($0.03) a share, for the same period of 2009. Exact’s net loss for the nine-month period ended September 30, 2010, was ($8.0) million, or ($0.21) a share, compared to ($7.3) million, or ($0.23) a share, for the same period of 2009.

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is trading 15.08% lower at $16.39 after the company found potential safety issues with its key kidney drug Feraheme, which reported declining sales, and said it will cut about a fourth of its workforce. 

The company said that while the 146 cases of serious adverse events it had found in a post-marketing study were within the serious event rate contained in its U.S. packaging insert, it also found life-threatening and fatal events following the study.

About Penny Stock Pick Report


Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on top stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.